À°·Á³°²Ê¡¦¥ê¥Ï¥Ó¥ê¥Æ¡¼¥·¥ç¥ó²Ê

¹¹¿·Æü¡§2011/08/08

¥¹¥¿¥Ã¥Õ

À¶¿åÁï»Ö

Éû±¡Ä¹À¶¿åÁï»Ö

¾¼ÏÂ61ǯÆÁÅçÂç³ØÂ´
°å³ØÇî»Î¡¦ÆüËÜÀ°·Á³°²Ê³Ø²ñÀìÌç°å¡¦ÆüËÜÀÔÄÇÀÔ¿ñɳزñ»ØÆ³°å¡¦ÆüËܥꥦ¥Þ¥Á³Ø²ñǧÄê°å


»ÔÀîůÌé

ÉôĹ»ÔÀîůÌé

Ê¿À®8ǯÉ;¾°å²ÊÂç³ØÂ´
ÆüËÜÀ°·Á³°²Ê³Ø²ñÀìÌç°å


»³²¼ÂçÊå

°åĹ»³²¼ÂçÊå

Ê¿À®17ǯÉ;¾°å²ÊÂç³ØÂ´


±±°æ³Ù

°å°÷±±°æ³Ù

Ê¿À®18ǯ´ä¼ê°å²ÊÂç³ØÂ´


½àÈ÷Ãæ

Èó¾ï¶Ð°å»ÕĹÌî¾¼

É;¾°å²ÊÂç³ØÀ°·Á³°²Ê̾ÍÀ¶µ¼ø


½àÈ÷Ãæ

Èó¾ï¶Ð°å»ÕµÚÀîÆ»Íº

Áí¹çÀÄ»³É±¡Éû±¡Ä¹


¿ÇÎÅÆâÍÆ

À°·Á³°²Ê¤Ï»Í»è³°½ý¡¢¹ü´ØÀá¼À´µ¡¢ÀÔÄÇ¡¦ÀÔ¿ñ¼À´µ¡¢Ëö¾¿¿À·Ð¼À´µ¤Ê¤É¤ò°·¤¦¿ÇÎŲʤǤ¹¡£Ê¿À®23ǯ4·î¸½ºß¤ÏÀ¶¿åÁï»Ö¡¢ »ÔÀîůÌé¡¢»³²¼ÂçÊå¡¢±±°æ³Ù¤Î¾ï¶Ð4¿ÍÂÎÀ©¤Ç¿ÇÎŤò¹Ô¤Ã¤Æ¤ª¤ê¡¢À¶¿å¤ÏÀÔÄÇ¡¦ÀÔ¿ñ¼À´µ¤ò¡¢»ÔÀ´ØÀá¼À´µ¡¢ »³²¼¤¬¾®»ùÀ°·Á¼À´µ¤òôÅö¤·¤Æ¤¤¤Þ¤¹¡£

ÀÔÄÇ¡¦ÀÔ¿ñ¼À´µ¤Ïºòǯ112·ï¤Î¼ê½Ñ¤¬¤¢¤ê¡¢ÎãǯÄ̤êºÇ¤â¿¤«¤Ã¤¿¤Î¤¬¹âÎð²½¼Ò²ñ¤òÈ¿±Ç¤·¤¿¹øÉôÀÔÃì´É¶¹ºõ¾É¼ê½Ñ¤Ç¤·¤¿¡£ ¤Ç¤­¤ë¤À¤±½Ñ¸åáÖÄˤξ¯¤Ê¤¤ÀÔÄǼê½Ñ¤ò¥Æ¡¼¥Þ¤Ë¼è¤êÁȤó¤Ç¤ª¤ê¡¢¸åÊý½ü°µ½Ñ¤Ï22­Ð·Â¤Î¥Á¥å¡¼¥Ö¥ì¥È¥é¥¯¥¿¡¼¤ò»ÈÍѤ·¤¿ ¸²Èù¶À¼ê½Ñ¤ò¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡£½ÑÍâÆü¤â¤·¤¯¤ÏÍ⡹Æü¤«¤éÊâ¹Ô³«»Ï¡¢¥³¥ë¥»¥Ã¥È¤ÎɬÍפâ̵¤¯¡¢Ä̾½µ´ÖÁ°¸å¤ÇÂౡ²Äǽ¤È ¤Ê¤ê¤Þ¤¹¡£ÊÑÀ­¤¹¤Ù¤ê¤äÊÑÀ­Â¦×¿¤Ê¤É¤ÎÀÔÃìÊÑÀ­¤Ë´Ø¤·¤Æ¤Ï¡¢¸ÇÄê½Ñ¤¬É¬ÍפȤʤ뤳¤È¤¬Â¿¤¤¤Î¤Ç¤³¤Î¸Â¤ê¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¹øÄˤ䲼»è¾É¾õ¤Ç³°Íè¤òˬ¤ì¤ë´µ¼Ô¤µ¤ó¤Ïǯ¡¹Áý²Ã¤·¤Æ¤¤¤Þ¤¹¤¬¡¢¤Û¤È¤ó¤É¤ÎÊý¤Ï°ÂÀÅ¡¢ÌôʪÎÅË¡¤Ê¤É¤ÎÊݸÎÅË¡¤Ç ²þÁ±¤·¤Æ¤¤¤­¤Þ¤¹¡£¤³¤ì¤é¤Î¾É¾õ¤Ç¤ªÇº¤ß¤ÎÊý¤Ï¤É¤¦¤¾¤ªµ¤·Ú¤Ë¤´ÁêÃ̤¯¤À¤µ¤¤¡£

´ØÀá¼À´µ¤Ç¤Ï¡¢É¨¡¢¸Ô´ØÀá¤Ê¤É¤Î¥È¥é¥Ö¥ë¤ÈÊÑ·ÁÀ­´ØÀá¾É¡¢¸ª´ØÀáÄË¡¢´ØÀá¥ê¥¦¥Þ¥Á¤Î¼£ÎŤËÎϤòÆþ¤ì¤Æ¤ª¤ê¤Þ¤¹¡£ ³°Íè¤Ç¤ÎÊݸ²ÃÎŤò´ðËܤȤ·¤Æ¡¢¼ê½Ñ²ÃÎŤ¬É¬ÍפǤ¢¤ì¤Ð¿×®¤ËÂбþ¤·¤Þ¤¹¡£É¨¡¢¸ª¤Î´ØÀá¶À¼ê½Ñ¤Ï¼ê½Ñ¿¯½±¤¬¾¯¤Ê¤¯¡¢ ¿ÇÃǤȼ£ÎŤËÍ­¸ú¤Ç¤¢¤êÀѶËŪ¤Ë¹Ô¤Ã¤Æ¤ª¤ê¤Þ¤¹¡£É¨¡¢¸Ô´ØÀá¤Î¿Í¹©´ØÀáÃÖ´¹½Ñ¤ÏËö´üÊÑ·ÁÀ­´ØÀá¾É¤Î½üÄˤËÍ¥¤ì¡¢ ¼ê½Ñ·ï¿ô¤âÁý²Ã¤·¤Æ¤ª¤ê¤Þ¤¹¡£Åö±¡¤Ç¤Ï½Ñ¸å1½µ¤ÇÊâ¹Ô¤¬¤Ç¤­¡¢3¡Á4½µÄøÅÙ¤ÎÆþ±¡¥ê¥Ï¥Ó¥ê²ÃÎŤˤè¤ê ²ÈÄíÉüµ¢¤·¤Æ¤¤¤¿¤À¤¤¤Æ¤ª¤ê¤Þ¤¹¡£Ä¹´ü´Ö²þÁ±¤Î¤Ê¤¤´ØÀáÄˤˤªÇº¤ß¤ÎÊý¤ÏÀ§Èó¤´ÁêÃ̲¼¤µ¤¤¡£

Ëè½µ²ÐÍËÆü¤Ë¤ÏĹÌî¾¼ÀèÀ¸¡ÊÉ;¾°åÂçÀ°·Á³°²Ê̾ÍÀ¶µ¼ø¡Ë¤Î¿ÇÎŤ¬¤¢¤ê¤Þ¤¹¡£¾å»èµ¡Ç½ºÆ·ú½Ñ¡¢Ëö¾¿¿À·Ð¼ê½Ñ¤Ê¤É¤ò ¼¹Åᤷ¤Æ¤¤¤¿¤À¤¤¤Æ¤¤¤Þ¤¹¡£ÏÓ¿À·ÐÁÑËãá㡢ʬÊÚËãáã¡¢¤½¤Î¾Ëö¾¿¿À·Ð¾ã³²¤ÎÀ¤³¦Åª¸¢°Ò¤Ç¤¹¤Î¤Ç¼õ¿Ç¤´´õ˾¤ÎÊý¤Ï À°·Á³°²Ê³°Íè¤Þ¤Ç¤ªÌ䤤¹ç¤ï¤»¤¯¤À¤µ¤¤¡£

¼ç¤ÊÂоݼÀ´µ

ÊÑ·ÁÀ­´ØÀá¾É¡¢ËýÀ­´ØÀá¥ê¥¦¥Þ¥Á¡¢ÊÑ·ÁÀ­ÀÔÄǾɡ¢¹øÄǤª¤è¤Ó·ÛÄÇÄÇ´ÖÈĥإë¥Ë¥¢¡¢¹øÉôÀÔÃì´É¶¹ºõ¾É¡¢¹üÀÞ¡¢¿ÙÂÓ»½ý¡¢ç§Â»½ý¡¢Ëö¾¿¿À·Ð¼À´µ¡¢¤½¤Î¾¹ü´ØÀá¼À´µ°ìÈÌ

¿ÇÎżÂÀÓ

  Ê¿À®22ǯ¼ê½Ñ·ï¿ô
ÀÔÄÇ 112Îã
ÂçÂܹü¶á°ÌÉô¹üÀÞ 86Îã
¤½¤Î¾»Í»è³°½ý 74Îã
´ØÀá¶À¼ê½Ñ 45Îã
´¶À÷¾É¡¢²õáÔ 27Îã
¿Í¹©´ØÀá 25Îã
Ëö¾¿¿À·Ð 15Îã
¼ðáç 10Îã
È´Å£¡¢ç§¾ä±ê¡¢¤½¤Î¾ 66Îã
¹ç·× 460·ï

¶ÈÀÓ

³Ø²ñȯɽ
Âè220²óÀ°·Á³°²Ê½¸Ã̲ñÅ쳤ÃÏÊý²ñ¡ÊÊ¿À®22ǯ6·î¡Ë
­´ØÀáÆâ´ØÀáÍ·Î¥ÂΤˤè¤ë­º¬´É¾É¸õ·²¤Î1Îã
¿¹²¬Áï¡¡À¶¿åÁï»Ö¡¡»ÔÀîůÌé¡¡»³²¼ÂçÊ塡ĹÌî¾¼

Âè222²óÀ°·Á³°²Ê½¸Ã̲ñÅ쳤ÃÏÊý²ñ¡ÊÊ¿À®22ǯ12·î¡Ë
ÂçÂܹü·ÛÉô¹üÀÞ¤ËÂФ¹¤ëDual SC Screw¥·¥¹¥Æ¥à¤Î¼£ÎÅÀ®ÀÓ
±±°æ³Ù¡¡À¶¿åÁï»Ö¡¡»ÔÀîůÌé¡¡»³²¼ÂçÊå

ÏÀʸ
Rheumatol Int 30 : 725-730 , 2010
Etanersept treatment reduceces the serum levels of interleukin-15 and interferon-gamma inducible protein-10
Tetuya Ichikawa , Yasunori Kageyama , Hayato Kobayashi , Norihiko Kato ,Kunio Tsujimura , Yukio Koide

³°Íè¿ÇÎÅɽ

  ·î ²Ð ¿å ÌÚ ¶â ÅÚ
8:30¡Á11:30

»ÔÀî

±±°æ

ĹÌî

»³²¼or±±°æ

»ÔÀî

À¶¿å

±±°æ

À¶¿å

»³²¼

¸òÂå

¸òÂå

8:30¡Á11:30
ͽÌó

À¶¿å

»ÔÀî

±±°æ

»³²¼

   
2:00¡Á4:00
ͽÌó
 

ĹÌî

¡¡

Âè4½µ
µÚÀî
(2:00¡Á5:00)

   

¢¨ÅÚÍËÆü¤Ï£²¿Ç¤ÇÀ¶¿å¡¢±±°æ¡¢»³²¼¤Î¸òÂåÀ©¤Ç¤¹

¢¨¸á¸å³°Íè¤ÏͽÌóÀ©¤Ç¤¹

¢¨ÌÚÍËÆü¤Î½é¿Ç³°Íè¤Ï¼ê½Ñ¤Î¤¿¤á¸á¸å3:00¡Á5:00¤ËÊѹ¹¤Ë¤Ê¤ë¤³¤È¤¬¤¢¤ê¤Þ¤¹

¿ÇÎÅÂÎÀ©É½ °ìÍ÷

↑¥Ú¡¼¥¸¤ÎÀèÆ¬¤Ø